Nov 11, 2020 / 01:00PM GMT
Evan David Seigerman - Crédit Suisse AG - Research Division - VP & Senior Equity Research Analyst
And we're live. Welcome, everyone, to Day 3 of the Crédit Suisse virtual health care conference. My name is Evan Seigerman. I'm the senior biopharma analyst here at Crédit Suisse. And for Day 3, it's my pleasure to have Moderna. And from Moderna, we have CEO, Stéphane Bancel; Dave Meline, CFO, I almost had to do a double take because last year I had him with his former employer, Amgen; and Lavina from the IR team. And it's my pleasure to have all 3 of you on. I know, Stéphane, you wanted to have a few slides, and then we're going to jump right into Q&A.
Stéphane Bancel - Moderna, Inc. - CEO & Director
Great. Well, Evan, thank you so much for having us, and I hope everybody is doing well.
I wont go and read you the forward-looking statement. You can find them in all our websites, but they're important, of course.
So let me give you a couple of quick updates. Of course, I'm sure we're
Moderna Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 11, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers